ADCs: the next generation of targeted therapies
Drug Discovery World
SEPTEMBER 25, 2024
Getting new targets for ADCs is a high priority as it could lead to therapies that are more likely to hit cancer cells, allowing for higher doses and greater efficacy with fewer trade-offs needed to ensure an acceptable safety profile.
Let's personalize your content